New risk tool could predict cancer return after liver surgery
NCT ID NCT07391007
First seen Feb 05, 2026 · Last updated Jun 13, 2026 · Updated 15 times
Summary
This observational study aims to develop a system that combines genetic and clinical data to predict which patients with colorectal cancer that has spread to the liver are at high risk of the cancer coming back after surgery. Researchers will study 200 adults aged 18-75 who have had complete removal of both the colon tumor and liver metastases. The goal is to use this risk information to guide personalized decisions about whether additional chemotherapy after surgery would be helpful.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL LIVER METASTASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, 200032, China
Conditions
Explore the condition pages connected to this study.